Research on myoma in Northeastern Romania and socio-medical outcomes
- PMID: 34824638
- PMCID: PMC8611495
- DOI: 10.3892/etm.2021.10952
Research on myoma in Northeastern Romania and socio-medical outcomes
Abstract
Myomas are the most common benign uterine tumors in women of childbearing age, with an incidence of up to 77% and a major impact on women's health. The aim of our study was to provide information concerning the incidence and prevalence of myomas in the patients admitted to a tertiary referral center in Northeastern Romania. This retrospective study conducted at the Iasi 'Cuza Voda' University Hospital of Obstetrics and Gynecology (Romania) included 11,538 patients, representing all patients admitted to the gynecology department between January 2013 and December 2019. During the study interval, the number of hysterectomies (total and for myomas) had increased. The rate of laparoscopic surgery showed a small decrease (31.3% from 34%), classic therapy showed a decrease by more than 10% and the hysteroscopy rate was tripled. There are few studies in the literature that have established with accuracy the incidence of myomas. In the present study, the prevalence of hysterectomy for myomas was 54.42%. Our results are in agreement with the data in the literature, namely that 40-60% of all performed hysterectomies are for myomas. The vast majority of admissions for myomas involve a surgical procedure most commonly hysterectomy.
Keywords: hysterectomy; myoma; myomectomy; quality of life; racial differences; women's health.
Copyright: © Matasariu et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.J Minim Invasive Gynecol. 2010 Mar-Apr;17(2):214-21. doi: 10.1016/j.jmig.2009.12.015. J Minim Invasive Gynecol. 2010. PMID: 20226411
-
Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.J Minim Invasive Gynecol. 2017 May-Jun;24(4):659-664. doi: 10.1016/j.jmig.2017.02.012. Epub 2017 Feb 17. J Minim Invasive Gynecol. 2017. PMID: 28216458
-
Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.J Minim Invasive Gynecol. 2017 Sep-Oct;24(6):1020-1028. doi: 10.1016/j.jmig.2017.05.021. Epub 2017 Jun 27. J Minim Invasive Gynecol. 2017. PMID: 28662989
-
Advances in management of uterine myomas.Front Biosci (Elite Ed). 2013 Jan 1;5(1):12-22. doi: 10.2741/e592. Front Biosci (Elite Ed). 2013. PMID: 23276966 Review.
-
Uterine artery embolization as a treatment option for uterine myomas.Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44. doi: 10.1016/j.ogc.2005.12.009. Obstet Gynecol Clin North Am. 2006. PMID: 16504811 Review.
Cited by
-
Intravascular leiomyoma‑A rare case in the context of Covid‑19 outbreak: A case report.Exp Ther Med. 2022 Nov 29;25(1):38. doi: 10.3892/etm.2022.11737. eCollection 2023 Jan. Exp Ther Med. 2022. PMID: 36569434 Free PMC article.
References
-
- Srivastava S, Mahey R, Kachhawa G, Bhatla N, Upadhyay AD, Kriplani A. Comparison of intramyometrial vasopressin plus rectal misoprostol with intramyometrial vasopressin alone to decrease blood loss during laparoscopic myomectomy: Randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2018;228:279–283. doi: 10.1016/j.ejogrb.2018.07.006. - DOI - PubMed
LinkOut - more resources
Full Text Sources